Maze Therapeutics, Inc. · NASDAQ:MAZE
Alphabet Holdings LLC reported a 5.50% stake in Maze Therapeutics, Inc. (Schedule 13G)
Event Mar 31, 2025 · Filed May 9, 2025
Alphabet Holdings LLC reported a 5.50% stake in Maze Therapeutics, Inc., 2,412,471 shares, as a passive investor on Mar 31, 2025. Filed May 9, 2025 (Schedule 13G).
- Stake
- 5.50%
- Shares
- 2,412,471
- Intent
- Passive
- What changed
- Crossed above 5%
- Filed together
- 9 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| GV 2019, L.P. | 4.10% | 1,807,907 |
| GV 2019 GP, L.P. | 4.10% | 1,807,907 |
| GV 2019 GP, L.L.C. | 4.10% | 1,807,907 |
| GV 2023, L.P. | 1.40% | 604,564 |
| GV 2023 GP, L.P. | 1.40% | 604,564 |
| GV 2023 GP, L.L.C. | 1.40% | 604,564 |
| Alphabet Holdings LLC | 5.50% | 2,412,471 |
| XXVI Holdings Inc. | 5.50% | 2,412,471 |
| Alphabet Inc. | 5.50% | 2,412,471 |
Source
Related
- Maze Therapeutics, Inc.
- Alphabet Holdings LLC
- Maze Therapeutics, Inc. shareholders
- Schedule 13G/A · Alphabet Holdings LLC · Feb 6, 2026
- Form 4 · Bernstein Harold · Oct 2, 2026
- Form 4 · Coloma Jason V · Oct 2, 2026
- Form 4 · Dandekar Atul · Oct 1, 2026
- Form 4 · Bernstein Harold · Sep 8, 2026
- Form 4 · Bernstein Harold · Sep 4, 2026